Mitochondrial Dynamics Modulation via MyoAAV-Mediated OPA1 Overexpression or BNIP3 Knockdown in Pancreatic Ductal Adenocarcinoma (PDAC)-Induced Cachexia
Disruption of mitochondrial dynamics and quality control precedes overt muscle wasting in cancer cachexia, but whether modulating it specifically in muscle in the presence of systemic wasting could preserve tissue mass and function remain elusive. We tested two independent, but complementary approaches in the orthotopic preclinical model of pancreatic ductal adenocarcinoma (KPC); inducing inner-mitochondrial membrane fusion through OPA1 overexpression and suppressing mitophagy via BNIP3 knockdown. Male and female C57BL/6J mice received bilateral intramuscular tibialis anterior (TA) injections of myotropic adeno-associated virus (MyoAAV) encoding murine either OPA1 cDNA or a BNIP3-targeting short hairpin RNA two weeks prior to orthotopic implantation of KPC1245 pancreatic cancer cells. Raw body and tissue weights, in vivo dorsiflexor torque and fatigability, TA fiber size and type, protein fractional synthesis rate, oxidative histochemistry, and selected molecular markers were assessed at the humane endpoint. Neither intervention prevented systemic wasting, however, in males, OPA1 overexpression partially attenuated TA mass loss, relieved torque deficits, and restored the proportion of type IIB fibers. Females developed a milder cachectic phenotype; OPA1 overexpression increased TA mass and shifted fiber composition toward type IIA fibers without any changes in torque. In males, BNIP3 knockdown markedly improved torque, restored fatigue resistance, preserved type IIB fiber proportion, and lowered DRP1 protein. Functional benefits concurred by BNIP3 shRNA delivery were accompanied by lower mixed-protein synthesis in both sexes. These findings support mitochondrial quality control as a therapeutic target while indicating that effective treatment will require calibrated, rather than maximal, suppression of mitochondrial turnover.